Evidence map›Paper›PMID 28976992›Full record

ArticlePloS one2017

Genetic determinants of serum 25-hydroxyvitamin D concentration during pregnancy and type 1 diabetes in the child.

Maija E Miettinen, Melissa C Smart, Leena Kinnunen, Valma Harjutsalo, Linnea Reinert-Hartwall, Irene Ylivinkka, Heljä-Marja Surcel, Christel Lamberg-Allardt, Graham A Hitman, Jaakko Tuomilehto

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 5 countries.

Maija E MiettinenChronic Disease Prevention Unit, National Institute for Health and Welfare, Helsinki, Finland.ORCID http://orcid.org/0000-0002-5587-7227
Melissa C SmartBlizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
Leena KinnunenGenomics and Biomarkers Unit, National Institute for Health and Welfare, Helsinki, Finland.
Valma HarjutsaloChronic Disease Prevention Unit, National Institute for Health and Welfare, Helsinki, Finland.
Linnea Reinert-HartwallVaccination Programme Unit, National Institute for Health and Welfare, Helsinki, Finland.
Irene YlivinkkaTranslational Cancer Biology Research Program, University of Helsinki, Helsinki, Finland.
Heljä-Marja SurcelImpact Assessment Unit, National Institute for Health and Welfare, Oulu, Finland.
Christel Lamberg-AllardtDepartment of Food and Environmental Sciences, Helsinki, Finland.
Graham A HitmanBlizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
Jaakko TuomilehtoChronic Disease Prevention Unit, National Institute for Health and Welfare, Helsinki, Finland.
Finnish Institute for Health and Welfare · FIUniversity of Helsinki · FIQueen Mary University of London · GBUniversität für Weiterbildung Krems · ATUniversity of Essex · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe in utero environment plays an important role in shaping development and later life health of the fetus. It has been shown that maternal genetic factors in the metabolic pathway of vitamin D associate with type 1 diabetes in the child. In this study we analyzed the genetic determinants of serum 25-hydroxyvitamin D (25OHD) concentration during pregnancy in mothers whose children later developed type 1 diabetes and in control mothers. STUDY

design474 mothers of type 1 diabetic children and 348 mothers of non-diabetic children were included in the study. We previously selected 7 single nucleotide polymorphisms (SNPs) in four genes in the metabolic pathway of vitamin D vitamin based on our previously published data demonstrating an association between genotype and serum 25OHD concentration. In this re-analysis, possible differences in strength in the association between the SNPs and serum 25OHD concentration in mothers of type 1 diabetic and non-diabetic children were investigated. Serum 25OHD concentrations were previously shown to be similar between the mothers of type 1 diabetic and non-diabetic children and vitamin D deficiency prevalent in both groups.

resultsAssociations between serum 25OHD concentration and 2 SNPs, one in the vitamin D receptor (VDR) gene (rs4516035) and one in the group-specific component (GC) gene (rs12512631), were stronger during pregnancy in mothers whose children later developed type 1 diabetes than in mothers whose children did not (pinteraction = 0.03, 0.02, respectively).

conclusionsWe show for the first time that there are differences in the strength of genetic determinants of serum 25OHD concentration during pregnancy between the mothers of type 1 diabetic and non-diabetic children. Our results emphasize that the in utero environment including maternal vitamin D metabolism should be important lines of investigation when searching for factors that lead to early programming of type 1 diabetes.

Indexed as

AdultCase-Control StudiesChildDiabetes Mellitus, Type 1FemaleHumansPolymorphism, Single NucleotidePregnancyVitamin D25-hydroxyvitamin DVitamin D

Identifiers

PMID28976992
PMCPMC5627909
OpenAlexW2763680064

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.